Advanced Proteome Therapeutics (TSXV:APC.H) EPS (Basic): C$-0.09 (TTM As of Apr. 2023)


What is Advanced Proteome Therapeutics EPS (Basic)?

Advanced Proteome Therapeutics TSXV:APC.H EPS (Basic) is C$-0.09 as of Apr. 2023.

Advanced Proteome Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Apr. 2023 was C$-0.05. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Apr. 2023 was C$-0.09.

Advanced Proteome Therapeutics's EPS (Diluted) for the three months ended in Apr. 2023 was C$-0.05. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2023 was C$-0.09.

Advanced Proteome Therapeutics's EPS without NRI for the three months ended in Apr. 2023 was C$-0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2023 was -0.05.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Advanced Proteome Therapeutics  (TSXV:APC.H) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Advanced Proteome Therapeutics EPS (Basic) Related Terms

Advanced Proteome Therapeutics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics EPS (Basic) Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.03 -0.03 -0.08 0.01

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.05

Advanced Proteome Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Advanced Proteome Therapeutics's Basic EPS for the fiscal year that ended in Jul. 2022 is calculated as

Basic EPS (A: Jul. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(0.983-0)/39.088
=0.03

Advanced Proteome Therapeutics's Basic EPS for the quarter that ended in Apr. 2023 is calculated as

Basic EPS (Q: Apr. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-1.993-0)/40.711
=-0.05

EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$-0.09 mean?
Advanced Proteome Therapeutics (TSXV:APC.H) has a EPS (Basic) of C$-0.09 as of Apr. 2023. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' EPS (Basic) too high?
Advanced Proteome Therapeutics' current EPS (Basic) is C$-0.09.
How does Advanced Proteome Therapeutics' EPS (Basic) compare to VRTX and REGN?
Advanced Proteome Therapeutics' EPS (Basic) of C$-0.09 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current EPS (Basic) is C$-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (TSXV:APC.H) has a current EPS (Basic) of C$-0.09. The current EPS (Basic) is C$-0.09. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Advanced Proteome Therapeutics (TSXV:APC.H), the current EPS (Basic) is C$-0.09 as of Apr. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.